Suppr超能文献

迷幻剂作用的神经基础。

The neural basis of psychedelic action.

机构信息

Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.

Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.

出版信息

Nat Neurosci. 2022 Nov;25(11):1407-1419. doi: 10.1038/s41593-022-01177-4. Epub 2022 Oct 24.

Abstract

Psychedelics are serotonin 2A receptor agonists that can lead to profound changes in perception, cognition and mood. In this review, we focus on the basic neurobiology underlying the action of psychedelic drugs. We first discuss chemistry, highlighting the diversity of psychoactive molecules and the principles that govern their potency and pharmacokinetics. We describe the roles of serotonin receptors and their downstream molecular signaling pathways, emphasizing key elements for drug discovery. We consider the impact of psychedelics on neuronal spiking dynamics in several cortical and subcortical regions, along with transcriptional changes and sustained effects on structural plasticity. Finally, we summarize neuroimaging results that pinpoint effects on association cortices and thalamocortical functional connectivity, which inform current theories of psychedelic action. By synthesizing knowledge across the chemical, molecular, neuronal, and network levels, we hope to provide an integrative perspective on the neural mechanisms responsible for the acute and enduring effects of psychedelics on behavior.

摘要

迷幻剂是血清素 2A 受体激动剂,可导致感知、认知和情绪发生深刻变化。在这篇综述中,我们专注于迷幻药物作用的基础神经生物学。我们首先讨论化学,突出显示精神活性分子的多样性以及控制其效力和药代动力学的原则。我们描述了血清素受体及其下游分子信号通路的作用,强调了药物发现的关键要素。我们考虑了迷幻剂对几个皮质和皮质下区域神经元尖峰动力学的影响,以及转录变化和对结构可塑性的持续影响。最后,我们总结了神经影像学结果,这些结果指出了迷幻剂对联合皮质和丘脑皮质功能连接的影响,为迷幻剂作用的当前理论提供了信息。通过综合化学、分子、神经元和网络水平的知识,我们希望对迷幻剂对行为的急性和持久影响的神经机制提供综合观点。

相似文献

1
The neural basis of psychedelic action.
Nat Neurosci. 2022 Nov;25(11):1407-1419. doi: 10.1038/s41593-022-01177-4. Epub 2022 Oct 24.
2
Psychedelics and the human receptorome.
PLoS One. 2010 Feb 2;5(2):e9019. doi: 10.1371/journal.pone.0009019.
3
Chemistry and Structure-Activity Relationships of Psychedelics.
Curr Top Behav Neurosci. 2018;36:1-43. doi: 10.1007/7854_2017_475.
4
Catalysts for change: the cellular neurobiology of psychedelics.
Mol Biol Cell. 2021 Jun 1;32(12):1135-1144. doi: 10.1091/mbc.E20-05-0340.
5
Beyond the 5-HT Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.
J Neurosci. 2023 Nov 8;43(45):7472-7482. doi: 10.1523/JNEUROSCI.1384-23.2023.
6
The costs and benefits of psychedelics on cognition and mood.
Neuron. 2023 Mar 1;111(5):614-630. doi: 10.1016/j.neuron.2022.12.031. Epub 2023 Jan 20.
7
Animal models of serotonergic psychedelics.
ACS Chem Neurosci. 2013 Jan 16;4(1):33-42. doi: 10.1021/cn300138m. Epub 2012 Sep 24.
10
In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT R.
J Neurochem. 2022 Jul;162(1):39-59. doi: 10.1111/jnc.15570. Epub 2022 Jan 17.

引用本文的文献

1
Disrupting Substance Use Disorder: The Chemistry of Iboga Alkaloids.
European J Org Chem. 2024 Sep 23;27(36). doi: 10.1002/ejoc.202400432. Epub 2024 Jul 7.
2
The ABCs of psychedelics: a preclinical roadmap for drug discovery.
Trends Pharmacol Sci. 2025 Aug 27. doi: 10.1016/j.tips.2025.07.017.
4
Psychoactive substances: novel molecular insights and therapeutic potential for Alzheimer's disease.
Transl Neurodegener. 2025 Jul 25;14(1):38. doi: 10.1186/s40035-025-00498-1.
5
What fMRI studies say about the nature of the psychedelic effect: a scoping review.
Front Neurosci. 2025 Jul 1;19:1606798. doi: 10.3389/fnins.2025.1606798. eCollection 2025.
7
Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.
Neurosci Appl. 2023 Dec 15;3:103929. doi: 10.1016/j.nsa.2023.103929. eCollection 2024.

本文引用的文献

1
Increased global integration in the brain after psilocybin therapy for depression.
Nat Med. 2022 Apr;28(4):844-851. doi: 10.1038/s41591-022-01744-z. Epub 2022 Apr 11.
2
"Selective" serotonin 5-HT receptor antagonists.
Biochem Pharmacol. 2022 Jun;200:115028. doi: 10.1016/j.bcp.2022.115028. Epub 2022 Apr 4.
3
Structure-based discovery of nonhallucinogenic psychedelic analogs.
Science. 2022 Jan 28;375(6579):403-411. doi: 10.1126/science.abl8615. Epub 2022 Jan 27.
4
Psychedelics.
Curr Biol. 2022 Jan 24;32(2):R63-R67. doi: 10.1016/j.cub.2021.12.009.
5
Synthon-based ligand discovery in virtual libraries of over 11 billion compounds.
Nature. 2022 Jan;601(7893):452-459. doi: 10.1038/s41586-021-04220-9. Epub 2021 Dec 15.
6
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.
Transl Psychiatry. 2021 Nov 8;11(1):574. doi: 10.1038/s41398-021-01706-y.
8
Psychedelics and Other Psychoplastogens for Treating Mental Illness.
Front Psychiatry. 2021 Oct 4;12:727117. doi: 10.3389/fpsyt.2021.727117. eCollection 2021.
9
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.
Trends Pharmacol Sci. 2021 Nov;42(11):929-942. doi: 10.1016/j.tips.2021.08.003. Epub 2021 Sep 24.
10
LSD degrades hippocampal spatial representations and suppresses hippocampal-visual cortical interactions.
Cell Rep. 2021 Sep 14;36(11):109714. doi: 10.1016/j.celrep.2021.109714.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验